BVF PARTNERS L P/IL Insider Trading Transactions

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for BVF PARTNERS L P/IL.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in KENT INTERNATIONAL HOLDINGS INC ($CRTQ) and 10% Owner in LIGAND PHARMACEUTICALS INC ($LGND) and 10% Owner in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in REPLIGEN CORP ($RGEN) and 10% Owner in AVIGEN INC \DE ($AVGN) and 10% Owner in NEUROCRINE BIOSCIENCES INC ($NBIX) and 10% Owner in Astex Pharmaceuticals, Inc ($SUPG) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ ($NTII) and 10% Owner in RIGEL PHARMACEUTICALS INC ($RIGL) and 10% Owner in ARRAY BIOPHARMA INC ($ARRY) and 10% Owner in DYNAVAX TECHNOLOGIES CORP ($DVAX) and 10% Owner in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and 10% Owner in CATALYST BIOSCIENCES, INC. ($CBIO) and 10% Owner in ICAGEN INC ($ICGN) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in Celera CORP ($CRA) and 10% Owner in ABBOTT BIOTHERAPEUTICS CORP ($FACT).

Latest Insider Trading Transactions of BVF PARTNERS L P/IL

Sentiment: All, FACT, ARQL, ARRY, SUPG, AVGN, CAPS, CBIO, CRA, CCXI, DVAX, CRXX, ICGN, CRTQ, LGND, NTII, NBIX, RGEN, RIGL

Page: < prev 1 2 3

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 23 2009	AVGN	AVIGEN INC \DE	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.50	277,000	415,500	7,837,815	8.1 M to 7.8 M (-3.41 %)
Oct 23 2009	AVGN	AVIGEN INC \DE	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.50	80,000	120,000	8,114,815	8.2 M to 8.1 M (-0.98 %)
Oct 23 2009	AVGN	AVIGEN INC \DE	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.50	115,200	172,800	8,194,815	8.3 M to 8.2 M (-1.39 %)
Jul 16 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.99	6,000	17,965	2,700,325	2.7 M to 2.7 M (+0.22 %)
Jul 16 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.99	2,000	5,988	2,694,325	2.7 M to 2.7 M (+0.07 %)
Jul 16 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.99	1,516	4,539	2,692,325	2.7 M to 2.7 M (+0.06 %)
Jul 13 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.89	1,000	2,891	2,690,809	2.7 M to 2.7 M (+0.04 %)
Jul 13 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.89	1,200	3,470	2,689,809	2.7 M to 2.7 M (+0.04 %)
Jul 13 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.79	1,000	2,789	2,688,609	2.7 M to 2.7 M (+0.04 %)
Jul 13 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	2.79	1,000	2,789	2,687,609	2.7 M to 2.7 M (+0.04 %)
Jul 13 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.10	12,000	37,198	2,686,609	2.7 M to 2.7 M (+0.45 %)
Jul 13 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.10	4,000	12,399	2,674,609	2.7 M to 2.7 M (+0.15 %)
Jul 13 2009	CBIO	CATALYST BIOSCIENC ...	BVF PARTNERS L P/IL	10% Owner	Buy	P	3.10	5,500	17,049	2,670,609	2.7 M to 2.7 M (+0.21 %)
Jul 08 2009	RGEN	REPLIGEN CORP	BVF PARTNERS L P/IL	10% Owner	Sell	S	5.50	1,000	5,500	2,765,050	2.8 M to 2.8 M (-0.04 %)
Jul 08 2009	RGEN	REPLIGEN CORP	BVF PARTNERS L P/IL	10% Owner	Sell	S	5.52	264,000	1,456,145	2,766,050	3 M to 2.8 M (-8.71 %)
Jul 08 2009	RGEN	REPLIGEN CORP	BVF PARTNERS L P/IL	10% Owner	Sell	S	5.52	76,000	419,193	3,030,050	3.1 M to 3 M (-2.45 %)
Jul 08 2009	RGEN	REPLIGEN CORP	BVF PARTNERS L P/IL	10% Owner	Sell	S	5.52	110,800	611,140	3,106,050	3.2 M to 3.1 M (-3.44 %)
Aug 26 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.57	2,669,000	6,859,330	10,617,400	13.3 M to 10.6 M (-20.09 %)
Aug 26 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.57	770,000	1,978,900	13,286,400	14.1 M to 13.3 M (-5.48 %)
Aug 26 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.57	1,113,550	2,861,824	14,056,400	15.2 M to 14.1 M (-7.34 %)
Jul 06 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.97	84,000	249,371	15,169,950	15.3 M to 15.2 M (-0.55 %)
Jul 06 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.97	24,000	71,249	15,253,950	15.3 M to 15.3 M (-0.16 %)
Jul 06 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.97	34,700	103,014	15,277,950	15.3 M to 15.3 M (-0.23 %)
Sep 11 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.76	711,000	1,965,631	4,278,851	5 M to 4.3 M (-14.25 %)
Sep 11 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.76	205,000	566,743	4,989,851	5.2 M to 5 M (-3.95 %)
Sep 11 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.76	296,106	818,615	5,194,851	5.5 M to 5.2 M (-5.39 %)
Aug 10 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.03	2,000	4,059	5,490,957	5.5 M to 5.5 M (-0.04 %)
Aug 10 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.03	1,000	2,029	5,492,957	5.5 M to 5.5 M (-0.02 %)
Aug 10 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.03	500	1,015	5,493,957	5.5 M to 5.5 M (-0.01 %)
Aug 10 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.00	232,000	464,951	5,494,457	5.7 M to 5.5 M (-4.05 %)
Aug 10 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.00	67,000	134,275	5,726,457	5.8 M to 5.7 M (-1.16 %)
Aug 10 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.00	97,000	194,398	5,793,457	5.9 M to 5.8 M (-1.65 %)
Aug 03 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	9,000	16,677	5,890,457	5.9 M to 5.9 M (-0.15 %)
Aug 03 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	3,000	5,559	5,899,457	5.9 M to 5.9 M (-0.05 %)
Aug 03 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	3,600	6,671	5,902,457	5.9 M to 5.9 M (-0.06 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	67,000	124,171	5,906,057	6 M to 5.9 M (-1.12 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	19,000	35,213	5,973,057	6 M to 6 M (-0.32 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	27,500	50,966	5,992,057	6 M to 6 M (-0.46 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	29,000	53,659	6,019,557	6 M to 6 M (-0.48 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	8,000	14,802	6,048,557	6.1 M to 6 M (-0.13 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.85	12,000	22,204	6,056,557	6.1 M to 6.1 M (-0.20 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.99	144,000	286,834	6,068,557	6.2 M to 6.1 M (-2.32 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.99	41,000	81,668	6,212,557	6.3 M to 6.2 M (-0.66 %)
Jul 29 2009	DVAX	DYNAVAX TECHNOLOGI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	1.99	60,100	119,713	6,253,557	6.3 M to 6.3 M (-0.95 %)
Sep 21 2009	ARQL	ARQULE INC	BVF PARTNERS L P/IL	10% Owner	Sell	S	5.25	2,100,000	11,025,000	8,564,073	10.7 M to 8.6 M (-19.69 %)
Sep 21 2009	ARQL	ARQULE INC	BVF PARTNERS L P/IL	10% Owner	Sell	S	5.25	660,000	3,465,000	10,664,073	11.3 M to 10.7 M (-5.83 %)
Sep 21 2009	ARQL	ARQULE INC	BVF PARTNERS L P/IL	10% Owner	Sell	S	5.25	920,000	4,830,000	11,324,073	12.2 M to 11.3 M (-7.51 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.94	35,000	103,030	15,312,650	15.3 M to 15.3 M (-0.23 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.94	10,000	29,437	15,347,650	15.4 M to 15.3 M (-0.07 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.94	13,616	40,081	15,357,650	15.4 M to 15.4 M (-0.09 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.93	281,000	822,599	15,371,266	15.7 M to 15.4 M (-1.80 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.93	81,000	237,119	15,652,266	15.7 M to 15.7 M (-0.51 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.93	117,256	343,255	15,733,266	15.9 M to 15.7 M (-0.74 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.90	171,000	495,336	15,850,522	16 M to 15.9 M (-1.07 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.90	49,000	141,938	16,021,522	16.1 M to 16 M (-0.30 %)
Jun 29 2009	LGND	LIGAND PHARMACEUTI ...	BVF PARTNERS L P/IL	10% Owner	Sell	S	2.87	71,393	204,876	16,070,522	16.1 M to 16.1 M (-0.44 %)

Page: < prev 1 2 3